LLY, MRK, PFE: Biopharma Is Back In 2024

Expect 2024 to be the year of gradual recovery for biopharmaceuticals, notes CFRA’s Sel Hardy. She and Jefferies’ Brian Tranquilut discuss health care trends to watch in 2024. Hardy mentions that oncology and diabetes will be the fastest growing therapy areas. Her top stock picks include Eli Lilly (LLY), Merck (MRK), and Pfizer (PFE). Tranquilut highlights that Jefferies continues to like HCA given the solid company fundamentals, reasonable valuation, and opportunity for earnings upside. Tune in to find out more about the stock market today.

Trading 360

11 Sep 2025

SHARE

Schwab Network's Newsletters

Daily insights for every investor

ON AIR
8:00 pm
Market Overtime
replay
12:00 am
The Wrap
REPLAY
12:30 am
Market On Close
REPLAY
2:00 am
Trading 360
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
5:00 am
Market Overtime
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Morning Movers
8:00 am
Opening Bell With Nicole Petallides
9:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Fast Market
REPLAY
5:00 pm
Next Gen Investing
REPLAY
6:00 pm
The Wrap
REPLAY
7:30 pm
Market Overtime
REPLAY
ON AIR
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market On Close
REPLAY
10:00 pm
Trading 360
REPLAY
11:00 pm
The Wrap
REPLAY